Moderna mRNA flu vaccine bests standard shot in peer-reviewed trial, FDA decision due in August May 08, 2026 · Colleen Cabili Results published in the New England Journal of Medicine show the mRNA shot reduced flu illness by about 27% more than a standard-dose vaccine Read more »
.png?branch=production&format=jpg&width=1024)
.jpg?branch=production&format=jpg&width=1024)
